[Cardiovascular risk calculators for people living with human immunodeficiency virus].

Calculadoras de riesgo cardiovascular en personas viviendo con el virus de la inmunodeficiencia humana.
Calculadoras Calculators Human immunodeficiency virus Riesgo cardiovascular Risk calculators Virus de la inmunodeficiencia humana

Journal

Hipertension y riesgo vascular
ISSN: 1989-4805
Titre abrégé: Hipertens Riesgo Vasc
Pays: Spain
ID NLM: 101510649

Informations de publication

Date de publication:
Historique:
received: 16 04 2020
revised: 01 06 2020
accepted: 26 06 2020
pubmed: 28 7 2020
medline: 21 10 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

The increasing access and efficacy of antiretroviral therapy has allowed people living with human immunodeficiency virus to achieve a life expectancy similar to that of the general population. However, this goal may be affected by the increased risk of cardiovascular disease in this group. This risk is multifactorial, involving the high prevalence of traditional risk factors, the development of a pro-inflammatory state related to chronic infection, and the use of antiretroviral drugs with an adverse metabolic profile. In daily practice, in order to estimate this risk and guide medical decision-making, different calculators are available. These are based on data from population cohorts, many of them from human immunodeficiency virusnegative subjects. The main aim of this review is to describe the epidemiology of cardiovascular disease in people living with human immunodeficiency virus, the available risk calculators and their use.

Identifiants

pubmed: 32709573
pii: S1889-1837(20)30066-0
doi: 10.1016/j.hipert.2020.06.004
pii:
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Review

Langues

spa

Sous-ensembles de citation

IM

Pagination

181-193

Informations de copyright

Crown Copyright © 2020. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

M Grand (M)

Instituto de Investigación en Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Olavarría, Argentina. Electronic address: marina.grand@hotmail.com.

A Diaz (A)

Instituto de Investigación en Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Olavarría, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, Centro Científico Tecnológico Tandil). Instituto de Investigación en Ciencias de la Salud, Facultad de Ciencias de la Salud, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil, Argentina.

D Bia (D)

Departamento de Fisiologia, Facultad de Medicina, Universidad de la Republica, Centro Universitario de Investigación, Innovación y Diagnóstico Arterial (CUiiDARTE), Universidad de la República General Flores, Montevideo, Uruguay.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH